| Accord Healthcare AG - Irinotecan Accord 1000 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 66766 | | 05 | | Irinotecan Accord 1000 mg/50 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01CE02 | | Irinotecan | | 06.05.2021 | | |
|
| Composition |
| irinotecani hydrochloridum trihydricum 1000 mg, acidum lacticum, sorbitolum 2250 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium max. 4.02 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Irinotecan Hydrochloride Trihydrate | 1000mg / 50ml |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Lactic Acid | | | Sodium Hydroxide | | | Sorbitol | 2250mg / 50ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | | PR | PR | A | | Yes |
|
